Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Verapamil derivative from Toa Eiyo with potential in supraventricular tachycardia

Dec. 18, 1997

Parke-Davis identifies selective FGF receptor tyrosine kinase inhibitor

Dec. 18, 1997

New dihydropyridine derivatives with cardiovascular activity from Mercian

Dec. 17, 1997

Sumitomo synthesizes new series of ECE inhibitors

Dec. 17, 1997

Spotlight on ACE inhibitor/calcium antagonist combinations

Dec. 16, 1997

CB1 receptors are activated in hemorrhagic shock

Dec. 16, 1997

Adenovirus-mediated delivery of human tissue kallikrein: novel gene therapy for hypertension

Dec. 15, 1997

E-4010: highly potent and selective PDE V inhibitor from Eisai

Dec. 15, 1997

Phase I trial of oral TBC-11251 successfully completed

Dec. 12, 1997

Effects of BO-653 and related compounds on various active oxygen species

Dec. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...